Medicine | Departments of Swiss TPH (Page)
https://www.swisstph.ch/fr/about/med
TPH provides a dedicated emergency service for diagnosing malaria - even outside regular working hours - and diagnoses approximately 200 malaria and over 1,200 schistosomiasis cases per year. Managing and [...] countries of Africa, Asia and Eastern Europe. The majority of our clinical research addresses issues of malaria, HIV, tuberculosis, causes-of-fever studies, and the evaluation of treatments and vaccines or their [...] Children 15.12.2023 Milestone in the Fight Against Sleeping Sickness...
Public and Global Health Short Courses |Study at Swiss TPH (Page)
https://www.swisstph.ch/fr/study-with-us/postgraduate/public-and-global-health-short-courses
information Online 5 weeks Field Malaria Course in Tanzania and Laos Enhance your capacity and expertise in malaria control and research to effectively address and manage malaria issues. Location Duration More [...] Resistant Mosquito: Staying Ahead of the Game in the Fight against Malaria (MOOC) Discover approaches and advances in our fight against the malaria mosquito using Insecticide Resistance Management (IRM). Location [...] cover a range of global and public health topics such as...
In vitro antiplasmodial activity and cytotoxicity of ethnobotanically selected Ivorian plants (Publications)
Eight extracts from four Ivorian medicinal plants, traditionally used to treat malaria, were tested for their antiplasmodial activity in vitro by assessing their ability to inhibit the uptake of [3H]h
Causes of fever in returning travelers: a European multicenter prospective cohort study (Publications)
diagnostic algorithm was used ensuring a systematic evaluation of all participants. After ruling out malaria, PCRs and serologies for dengue, chikungunya and Zika viruses were performed in all patients presenting
Estimation of the antirelapse efficacy of tafenoquine, using <em>Plasmodium vivax</em> genotyping (Publications)
Plasmodium vivax relapse prevention is a key treatment goal in malaria. Use of P. vivax genotyping in a multicenter, double-blind, randomized, placebo-controlled Phase IIb study in Peru, India, Thailand
Synthesis of 3-azabicyclo[3.2.2]nonanes and their antiprotozoal activities (Publications)
The new compounds were tested for their activities against one strain of the causative organism of Malaria tropica, Plasmodium falciparum K1, which is resistant against chloroquine and pyrimethamine. In addition
Novel nucleoside-based antimalarial compounds (Publications)
The malaria-causing parasite Plasmodium falciparum employs a salvage pathway for the biosynthesis of nucleotides, in contrast to de novo biosynthesis that is utilized by the human host. A series of twenty-two
Causes of fever in returning travelers: a European multicenter prospective cohort study (Publications)
diagnostic algorithm was used ensuring a systematic evaluation of all participants. After ruling out malaria, PCRs and serologies for dengue, chikungunya and Zika viruses were performed in all patients presenting
Novel nucleoside-based antimalarial compounds (Publications)
The malaria-causing parasite Plasmodium falciparum employs a salvage pathway for the biosynthesis of nucleotides, in contrast to de novo biosynthesis that is utilized by the human host. A series of twenty-two
Estimation of the antirelapse efficacy of tafenoquine, using <em>Plasmodium vivax</em> genotyping (Publications)
Plasmodium vivax relapse prevention is a key treatment goal in malaria. Use of P. vivax genotyping in a multicenter, double-blind, randomized, placebo-controlled Phase IIb study in Peru, India, Thailand